Screening of OXA-244 producers, a difficult-to-detect and emerging OXA-48 variant?

被引:24
|
作者
Emeraud, Cecile [1 ,2 ,3 ,4 ]
Biez, Laura [2 ,4 ]
Girlich, Delphine [2 ,4 ]
Jousset, Agnes B. [1 ,2 ,3 ,4 ]
Naas, Thierry [1 ,2 ,3 ,4 ]
Bonnin, Remy A. [2 ,3 ,4 ]
Dortet, Laurent [1 ,2 ,3 ,4 ]
机构
[1] Bicetre Hosp, Assistance Publ Hop Paris, Dept Bacteriol Hyg, Le Kremlin Bicetre, France
[2] Paris Saclay Univ, UMR S 1184, Le Kremlin Bicetre, France
[3] French Natl Reference Ctr Antibiot Resistance, Le Kremlin Bicetre, France
[4] Paris Saclay Univ, Fac Med, Le Kremlin Bicetre, France
关键词
CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE; BETA-LACTAMASE;
D O I
10.1093/jac/dkaa155
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: OXA-244, a single amino acid variant of OXA-48, demonstrates weaker hydrolytic activity towards carbapenems and temocillin compared with OXA-48. Of note, these antimicrobials are present in high concentrations in several carbapenemase-producing Enterobacterales (CPE) screening media. As a result, some screening media fail to grow OXA-244-producing isolates, while the prevalence of OXA-244 producers is constantly increasing in France. Methods: Here, we evaluate the performance of three commercially available CPE screening media [ChromID (R) CARBA SMART (bioMerieux), Brilliance (TM) CRE (Thermo Fisher) and mSuperCARBA (TM) (MAST Diagnostic)] for their ability to detect OXA-244 producers (n = 101). As OXA-244 producers may also express an ESBL, two additional ESBL screening media were tested (Brilliance (TM) ESBL and ChromID (R) BLSE). MICs of temocillin and imipenem were determined by broth microdilution. The clonality of OXA-244-producing Escherichia coli isolates (n = 97) was assessed by MLST. Results: Overall, the sensitivity of the ChromID (R) CARBA SMART, Brilliance (TM) CRE and mSuperCARBA (TM) media were 14% (95% CI = 8.1%-22.5%), 54% (95% CI = 43.3%-63.4%) and 99% (95% CI = 93.8%-100%), respectively, for the detection of OXA-244 producers. Among the 101 OXA-244-producing isolates, 96% were E. coli and 77%-78% grew on ESBL screening media. MLST analysis identified five main STs among OXA-244-producing E. coli isolates: ST38 (n = 37), ST361 (n = 17), ST69 (n = 12), ST167 (n = 11) and ST10 (n = 8). Conclusions: Our results demonstrated that the mSuperCARBA (TM) medium is very efficient in the detection of OXA-244 producers, unlike the ChromID (R) CARBA SMART medium. The high prevalence of ESBLs among OXA-244 producers allowed detection of 77%-78% of themusing ESBL-specific screening media.
引用
收藏
页码:2120 / 2123
页数:4
相关论文
共 19 条
  • [1] Biochemical characterization of OXA-244, an emerging OXA-48 variant with reduced β-lactam hydrolytic activity
    Rima, Mariam
    Emeraud, Cecile
    Bonnin, Remy A.
    Gonzalez, Camille
    Dortet, Laurent
    Iorga, Bogdan I.
    Oueslati, Saoussen
    Naas, Thierry
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (08) : 2024 - 2028
  • [2] Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain
    Oteo, Jesus
    Manuel Hernandez, Juan
    Espasa, Mateu
    Fleites, Ana
    Saez, David
    Bautista, Veronica
    Perez-Vazquez, Maria
    Dolores Fernandez-Garcia, Ma
    Delgado-Iribarren, Alberto
    Sanchez-Romero, Isabel
    Garcia-Picazo, Luisa
    Dolores Miguel, Ma
    Solis, Sonia
    Aznar, Esteban
    Trujillo, Gloria
    Mediavilla, Concepcion
    Fontanals, Dionisia
    Rojo, Susana
    Vindel, Ana
    Campos, Jose
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (02) : 317 - 321
  • [3] Characterisation of OXA-244, a chromosomally-encoded OXA-48-like β-lactamase from Escherichia coli
    Potron, Anais
    Poirel, Laurent
    Dortet, Laurent
    Nordmann, Patrice
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 47 (01) : 102 - 103
  • [4] Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181
    Gonzalez, Camille
    Oueslati, Saoussen
    Rima, Mariam
    Nermont, Reva
    Dortet, Laurent
    Hopkins, Katie L.
    Iorga, Bogdan I.
    Bonnin, Remy A.
    Naas, Thierry
    MICROORGANISMS, 2024, 12 (07)
  • [5] Role of amino acid 159 in carbapenem and temocillin hydrolysis of OXA-933, a novel OXA-48 variant
    Rima, Mariam
    Oueslati, Saoussen
    Cotelon, Garance
    Creton, Elodie
    Bonnin, Remy A.
    Dortet, Laurent
    Iorga, Bogdan I.
    Naas, Thierry
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (05)
  • [6] Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity
    Oueslati, Saoussen
    Retailleau, Pascal
    Marchini, Ludovic
    Dortet, Laurent
    Bonnin, Remy A.
    Iorga, Bogdan I.
    Naas, Thierry
    MICROORGANISMS, 2020, 8 (01)
  • [7] Use of avibactam to detect Ambler class A carbapenemases and OXA-48 β-lactamases in Enterobacteriaceae
    Porres-Osante, Nerea
    de Champs, Christophe
    Dupont, Herve
    Torres, Carmen
    Mammeri, Hedi
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 79 (03) : 399 - +
  • [8] Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant
    Dabos, Laura
    Raczynska, Joanna E.
    Bogaerts, Pierre
    Zavala, Agustin
    Girlich, Delphine
    Bonnin, Remy A.
    Dortet, Laurent
    Peyrat, Aurelie
    Retailleau, Pascal
    Iorga, Bogdan I.
    Jaskolski, Mariusz
    Glupczynski, Youri
    Naas, Thierry
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (02)
  • [9] OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem
    Kasap, Murat
    Torol, Sinem
    Kolayli, Fetiye
    Dundar, Devrim
    Vahaboglu, Haluk
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2013, 28 (05) : 990 - 996
  • [10] Prevalence of a New Variant OXA-204 and OXA-48 Carbapenemases Plasmids Encoded in Klebsiella pneumoniae Clinical Isolates in Tunisia
    Ouertani, Rym
    Ben Jomaa-Jemili, Mariem
    Gharsa, Haythem
    Limelette, Anne
    Guillard, Thomas
    Brasme, Lucien
    de Champs, Christophe
    Chouchani, Chedly
    MICROBIAL DRUG RESISTANCE, 2018, 24 (02) : 142 - 149